View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
November 26, 2019

Eko Devices unveils new generation of digital stethoscopes

Digital health firm Eko Devices has released the second generation of its CORE digital stethoscope technology to enable medical professionals to screen for heart ailments.

Digital health firm Eko Devices has released the second generation of its CORE digital stethoscope technology to enable medical professionals to screen for heart ailments.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The new version of CORE offerings will be available either as a fully assembled digital stethoscope (CORE Digital Stethoscope) or as an attachment for most existing stethoscopes (CORE Digital Attachment).

CORE Digital Attachment and CORE Digital Stethoscope will be available on Eko’s website to the healthcare providers for $199 and $249, respectively.

The redesigned Eko core features active noise cancellation, sleeker design and upgraded software.

Eko co-founder and CEO Connor Landgraf said: “When heart and lung sounds are amplified in the screening of heart valve and pulmonary diseases, everything changes.

“Our mission at Eko continues to be to enable all healthcare professionals to provide the highest level of cardiac care through non-invasive, reliable products. The redesigned CORE puts the ears of a trained cardiologist in the hands of any doctor or nurse.”

The company claims that the offerings will overcome the barriers associated with the analogue stethoscopes.

Eko clinical research vice president Steve Pham said:  “The better we can hear and the better we can screen, the better we can care for our patients. The CORE, coupled with Eko’s software, helps convert the device already worn around the neck of 30 million clinicians around the world into a powerful cardiopulmonary screening tool.”

CORE Digital Attachment and CORE Digital Stethoscope claim the products come with up to 40x sound amplification, active noise cancellation, as well as wireless Bluetooth connectivity.

By using Eko’s redesigned core, healthcare providers can easily switch between acoustic and digital modes.

It also comes with a lithium-ion battery, with a battery back-up of up to 10 hours.

With a one-click recording button, Eko’s software allows users to save recordings and share them with others.

Waveforms and phonocardiograms can also be viewed through the app.

Eko has also developed screening algorithms to help clinicians analyse heartbeats, which is currently awaiting FDA approval.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network